Major Thrombotic Event Despite Anticoagulation in a Patient With COVID-19
| Autor: | Joseph Ng, Aman Sharma, Basma Ataallah, Sharmiz Tamanna, Gregory Haggerty |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
pulmonary embolism Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infectious Disease therapeutic anticoagulation 030204 cardiovascular system & hematology coagulopathy 03 medical and health sciences 0302 clinical medicine Internal medicine Internal Medicine medicine Coagulopathy thrombosis business.industry Incidence (epidemiology) General Engineering Outbreak Hematology medicine.disease Thrombosis Pulmonary embolism covid-19 business 030217 neurology & neurosurgery Thrombotic complication |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.8896 |
| Popis: | The outbreak of coronavirus disease 2019 (known as COVID-19), which started in Wuhan, China in December 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been associated with both venous and arterial thromboembolism likely secondary to significant cytokine activation and inflammation. Reports on the incidence of thrombotic complications, however, are not well documented. Our case will examine a young man diagnosed with COVID-19 who developed an acute, severe bilateral saddle pulmonary embolism while on prophylactic dose anticoagulation after being admitted to the hospital and treated for two weeks with significant improvement. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|